Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Rigel Pharmaceuticals (RIGL)

Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Rigel: Q2 Earnings Snapshot AP - Tue Aug 4, 3:08PM CDT

Rigel: Q2 Earnings Snapshot

RIGL : 39.98 (-1.24%)
Rigel Reports Second Quarter 2026 Financial Results PR Newswire - Tue Aug 4, 3:01PM CDT

SOUTH SAN FRANCISCO, Calif. , Aug. 4, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today...

RIGL : 39.98 (-1.24%)
Rigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results PR Newswire - Tue Jul 28, 7:05AM CDT

SOUTH SAN FRANCISCO, Calif. , July 28, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its second quarter 2026 financial results after market...

RIGL : 39.98 (-1.24%)
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) PR Newswire - Tue Jul 7, 7:05AM CDT

SOUTH SAN FRANCISCO, Calif. , July 7, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL) today announced that it has granted awards pursuant to the Rigel Pharmaceuticals, Inc....

RIGL : 39.98 (-1.24%)
Rigel Appoints Board Member Alison L. Hannah, M.D. as Chief Medical Officer PR Newswire - Wed Jul 1, 7:05AM CDT

SOUTH SAN FRANCISCO, Calif. , July 1, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today...

RIGL : 39.98 (-1.24%)
Rigel Announces Closing of Licensing Agreement for VEPPANU™ (vepdegestrant) PR Newswire - Tue Jun 16, 3:01PM CDT

SOUTH SAN FRANCISCO, Calif. , June 16, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today...

RIGL : 39.98 (-1.24%)
Rigel to Present at the Jefferies Global Healthcare Conference PR Newswire - Wed May 27, 7:05AM CDT

SOUTH SAN FRANCISCO, Calif. , May 27, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today...

RIGL : 39.98 (-1.24%)
Rigel Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting and EHA2026 Congress PR Newswire - Thu May 21, 4:17PM CDT

SOUTH SAN FRANCISCO, Calif. , May 21, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today...

RIGL : 39.98 (-1.24%)
Rigel to Present at the 2026 RBC Capital Markets Global Healthcare Conference PR Newswire - Thu May 14, 7:05AM CDT

SOUTH SAN FRANCISCO, Calif. , May 14, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today...

RIGL : 39.98 (-1.24%)
Rigel Enters Exclusive Global Licensing Agreement for VEPPANU™ (vepdegestrant), an oral PROTAC, for the Treatment of 2L+ ER+/HER2-, ESR1m Advanced or Metastatic Breast Cancer PR Newswire - Tue May 12, 6:00AM CDT

SOUTH SAN FRANCISCO, Calif. , May 12, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today...

RIGL : 39.98 (-1.24%)

Barchart Exclusives

October Live Cattle Futures Just Hit a Three-Week High. A Buying Opportunity May Be in Sight. Barchart - 19 minutes ago
October live cattle futures have been trending up. More price strength could signal a buying opportunity for traders. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.